News and Comments

BIOTECHNOLOGY PROMISES A HUGE GROWTH

  Wednesday, December 21, 2011

EXELIXIS’ (EXEL) advanced PI3K-delta research and development preclinical program attracted Merck, known as MSD outside of the United States and Canada. “PI3K-delta is therapeutic target that academic researchers and the drug industry are racing to develop therapeutic antagonists for both inflammatory diseases and cancer. To get to Exelixis program, Merck agreed to pay $12 million in upfront payment in addition to potential milestone payments for multiple indications of up to $239 million and royalties on net-sales of products that would emerge from the agreement. Merck will also pay Exelixis royalties on any compounds that would emerge from Exelixis’ PI3K-delta program or from certain compounds that arise from Merck’s internal discovery efforts targeting PI3K-delta during a certain period. More...


Recent Postings


Archive


Tags

TOKAI (TKAOI) Bristol-Myers Squibb (BMY) Sequenom (SQNM) Zerenex Xoma (XOMA) ImmunoGen (IMGN) Dynavax (DVAX) SYNTA (SNTA) Aimmune Therapeutics (AIMT) Sanofi (SNY) Valeant Pharmaceuticals International (VRX) Dendreon (DNDN) Advaxis (ADXS) HALOZYME (HALO) Inovio (INO) ISIS (ISIS) ZALTRAP™ Agenus (AGEN) AGOS (ARGS) Elan (ELN) ARCA (ABIO) Theravance Bio Pharma (TBPH) Jazz Pharmaceuticals (JAZZ) Ridaforolimus Array Pharmaceuticals (ARRY) IDERA (IDRA) Biogen Idec (BIIB) KERYX (KERX) Spike Therapeutics (ONCE) NOVOCURE (NVCR) Alnylam (ALNY) Bellicum (BLCM) Merck (MRK) Anacor (ANAC) GUARDIAN HEALTH Regeneron (REGN) Anadys (ANDS) Roche (ROCHE) Gilead (GILD) Prosensa (RNA) Alder Biopharmaceuticals (ALDR) Illumina (ILMN) Mirati Therapeutics (MRTX) Incyte (INCY) Sarepta (SRPT) Tysabri JUNO (JUNO) Amgen (AMGN) Adaptimmune (ADAP) AERIE PHARMACEUTICALS Roche (RHHBY) ABBVIE (ABBV) Intrexon (XON) Galena (GALE) Exelixis (EXEL) Sangamo (SGMO) Pluristem (PSTI) Telaprevir Trastuzumab-DM1 Human Genome Sciences (HGSI) Theravance (THRX) Ziofpharm (ZIOP) SERES THERAPEUTICS (MCRB) Idenix (IDIX) AstraZeneca (AZN) PTC Therapeutics (PTCT) CompuGen (CGEN) Ariad (ARIA) Human Longevity (HLI) INNOVIVA (INVA) Vitae Pharmaceuticals (VTAE) Seattle Genetics (SGEN) RenenxBio (RGNX) Herceptin Velcade (bortezomib) ADVENTRIX (ANX) Cytokinetics (CYTK) BIOMARIN (BMRN) Sanofi (SNA) Sanofi-Aventis (SAN) Auspex (ASPX) Rapamune Onyx (ONXX) SUNESIS PHARMACEUTICALS (SNSS) Intermune (ITMN) Ionis (IONS) Benlysta (belimumab) Endometrial Cancer Micromet (MITI) NANTKWEST (NK) Revlimid (lenolidamide) OSI (OSIP) GlaxoSmithKline (GSK) ACADIA (ACAD) C4 Therapeutics Genentech Global Cell Therapeutics (GBT) Multiple Myeloma Intercept (ICPT) ARGOS (ARGS) Abbott Laboratories (ABT) Prolor Biotech (PBTH) galapagos (GLPG) VANDA (VNDA) Agenus (AGEN Biocryst (BCRX) Editas (EDIT) NEKTAR (NKTR)) REGULUS (RGLS) KITE (KITE) MODERNA Vertex (VRTX)